- SEK965.73m
- SEK836.63m
- SEK441.90m
Brief: C Rad Q2 Rev Up At SEK 129.4 Mln
Brief: C Rad To Repurchase Up To 100,000 Own Class B Shares
Brief: C-Rad Appoints Linda Frölén As New CFO
Brief: C-Rad Appoints Jonas Reinhammar As Interim CFO
Brief: C Rad Q1 EBIT Up At SEK 14.2 Mln
Brief: C Rad CFO Christoffer Herou Resigns
Brief: C-Rad Gets Order Of SEK 12 Mln From Italy
Brief: Supreme Court Denies C-Rad's Leave To Appeal In Case Regarding Former Employee's Claim
Brief: C Rad Q4 EBIT Amounted To SEK 24.8 Mln
Brief: C-Rad Wins Order In Croatia Of SEK 16 Mln
Brief: C-Rad Announces Order From Accuray
Brief: C-Rad Gets Order In South Korea Worth About SEK 10 Mln
Brief: C Rad Gets Order For Cancer Care Solutions In UK Worth SEK 7.8 Mln
Brief: C Rad Q3 Operating Profit Rises To SEK 18.9 Million
Brief: C Rad Signs Agreement Worth SEK 8 Mln
Brief: C Rad Signs Agreement Valued At SEK 16 Mln In Germany
Brief: Atrium Health Levine Cancer To Help Patients Fight Cancer
Brief: C-Rad, Katholisches Klinikum Bochum Sign Partnership Agreement
Brief: Former C Rad Employee Appeals Verdict From Patent And Market Court Of Appeal